Prognostic Value of Perineural Invasion in Patients with Stage II Colorectal Cancer
Authors:
- 25 February 2010
- journal article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 17 (8) , 2066-2072
Abstract
Perineural invasion (PNI) may influence the prognosis after resection of colorectal cancer (CRC); whether this is a definite prognostic factor remains controversial. This study determined the clinicopathologic factors associated with oncologic outcome after radical resection of stage II CRC, focusing on PNI. We retrospectively reviewed 341 consecutive patients who underwent curative surgery for stage II CRC between January 2001 and December 2006. Of these, 278 patients (81.5%) received postoperative 5-fluorouracil-based chemotherapy. The oncologic outcomes and the risk factors for recurrence were analyzed. PNI was detected in 57 of 341 patients (16.7%) and was significantly associated with depth of tumor invasion (P = .035) and positive lymphovascular invasion (P < .001). Multivariate analyses revealed that PNI was a significant independent prognostic factor for disease-free survival, not for overall survival. With a median follow-up period of 57.6 months, the 5-year disease-free and overall survival rates of the patients were 80.2 and 82.6%, respectively. The 5-year disease-free survival of the PNI-negative group was significantly higher than that of the PNI-positive group (P < .001). Within the PNI-positive patients, those receiving chemotherapy had significantly higher 5-year disease-free survival than the others (P = .023). This study illustrates the value of PNI as a prognostic factor for stage II CRC. Moreover, PNI-positive patients should be considered for postoperative chemotherapy.Keywords
This publication has 30 references indexed in Scilit:
- Cancer Invasion to Auerbach's Plexus is an Important Prognostic Factor in Patients with pT3-pT4 Colorectal CancerDiseases of the Colon & Rectum, 2007
- Colon Cancer Clinical Practice Guidelines in OncologyJournal of the National Comprehensive Cancer Network, 2005
- Colon Cancer Survival Rates With the New American Joint Committee on Cancer Sixth Edition StagingJNCI: Journal of the National Cancer Institute, 2004
- A phase I trial of humanized monoclonal antibody huA33 in patients with early gastric cancer: Imaging studies, biodistribution, pharmacokinetics, immunohistochemistry, and quantitative tumor uptakeJournal of Clinical Oncology, 2004
- Prognostic Variables for Cancer-Related Survival in Node-Negative Colorectal CarcinomasDigestive Surgery, 2004
- Identifying patients with T3-T4 node-negative colon cancer at high risk of recurrenceDiseases of the Colon & Rectum, 2001
- Criteria for extramural perineural invasion as a prognostic factor in rectal cancerBritish Journal of Surgery, 2001
- Comparative Efficacy of Adjuvant Chemotherapy in Patients With Dukes' B Versus Dukes' C Colon Cancer: Results From Four National Surgical Adjuvant Breast and Bowel Project Adjuvant Studies (C-01, C-02, C-03, and C-04)Journal of Clinical Oncology, 1999
- Resection of hepatic and pulmonary metastases in patients with colorectal carcinomaCancer, 1998
- Adjuvant chemotherapy in Dukes' B and C colorectal cancer has only a minor influence on psychological distressSupportive Care in Cancer, 1997